SOX2 inhibits apoptosis via MAP4K4-Survivin signaling in lung cancer cells [33] and promotes metastasis of breast and prostate cancer cells by promoting epithelial-to-mesenchymal transition via the WNT/ β-catenin signal network [34]. This evidence concerns the gene SOX2 and prostate carcinoma.